CVS Can't Escape FCA Suit Alleging Drugmaker Collusion

By Daniel Wilson · March 13, 2023, 11:01 PM EDT

A Pennsylvania federal judge has refused to dismiss a whistleblower False Claims Act suit accusing CVS units of colluding with drugmakers to keep Medicare beneficiaries from accessing certain generic drugs, finding...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

ELLSWORTH ASSOCIATES, LLP et al v. CVS HEALTH CORPORATION et al

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Qui Tam (31 U.S.C. § 3729(a))

Date Filed

June 12, 2019

Recent Articles By Daniel

November 04, 2024
VA Accused Of Choosing 'Pass-Through' Co. For $257M Deal
October 28, 2024
Gov't Says No Duty To Pay $69M In COVID Testing Claims
October 01, 2024
Novel FCA Decision Amplifies Voices Of Whistleblower Critics
September 27, 2024
Fed. Circ. Won't Revive $5.9M CMS Contingency Fee Suit
September 25, 2024
Novel Labor Clause Ruling May Beg Scrutiny In Court
September 20, 2024
Judge Says $116M CIA Deal Protest Is Pot Calling Kettle Black
September 09, 2024
House OKs Bill To Bar Contracts With Chinese Biotech Cos.
September 04, 2024
Groups Urge DC Circ. To Reject Pharma Terrorism Liability Claims
August 15, 2024
NIH Accused Of Wrongly Eliminating Cos. From $50B IT Deal
August 12, 2024
GAO Says VA Deal Awardee Wasn't Missing Key Staff Member